Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name zandelisib
Trade Name
Synonyms ME401|PWT-143|PWT143|ME-401
Drug Descriptions

Zandelisib (ME-401) is a selective Pi3kd inhibitor that inhibits PI3K/AKT pathway signaling to decrease cell proliferation and induce cell death (PMID: 31506873).

DrugClasses PIK3CD inhibitor 26
CAS Registry Number 1595129-71-7
NCIT ID C123925


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Cyclophosphamide + Doxorubicin + Prednisone + Rituximab + Vincristine Sulfate + zandelisib Cyclophosphamide Doxorubicin Prednisone Rituximab Vincristine Sulfate zandelisib 0 1
Rituximab + zandelisib Rituximab zandelisib 0 2
Tazemetostat + zandelisib Tazemetostat zandelisib 0 1
zandelisib zandelisib 0 2

Additional content available in CKB BOOST